[1]
Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis., Escourrou J,Deprez P,Saggioro A,Geldof H,Fischer R,Maier C,, Alimentary pharmacology & therapeutics, 1999 Nov [PubMed PMID: 10571605]
[2]
Guidelines for prevention of NSAID-related ulcer complications., Lanza FL,Chan FK,Quigley EM,, The American journal of gastroenterology, 2009 Mar [PubMed PMID: 19240698]
[3]
Randomized clinical trial: the impact of gastrointestinal risk factor screening and prophylactic proton pump inhibitor therapy in patients receiving dual antiplatelet therapy., Jensen BES,Hansen JM,Larsen KS,Junker AB,Lassen JF,Jensen SE,Schaffalitzky de Muckadell OB,, European journal of gastroenterology & hepatology, 2017 Jul 3 [PubMed PMID: 28678044]
[4]
International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding., Barkun AN,Bardou M,Kuipers EJ,Sung J,Hunt RH,Martel M,Sinclair P,, Annals of internal medicine, 2010 Jan 19 [PubMed PMID: 20083829]
[5]
Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis., Dettmer A,Vogt R,Sielaff F,Lühmann R,Schneider A,Fischer R,, Alimentary pharmacology & therapeutics, 1998 Sep [PubMed PMID: 9768529]
[6]
Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study., Bianchi Porro G,Lazzaroni M,Imbesi V,Montrone F,Santagada T,, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2000 Apr [PubMed PMID: 10975769]
[7]
Clarithromycin versus Gemifloxacin in Quadruple Therapeutic Regimens for <i>Helicobacter Pylori</i> Infection Eradication., Mansour-Ghanaei F,Pedarpour Z,Shafaghi A,Joukar F,, Middle East journal of digestive diseases, 2017 Apr [PubMed PMID: 28638586]
[8]
Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial., Zargar SA,Javid G,Khan BA,Yattoo GN,Shah AH,Gulzar GM,Sodhi JS,Mujeeb SA,Khan MA,Shah NA,Shafi HM,, Journal of gastroenterology and hepatology, 2006 Apr [PubMed PMID: 16677158]
[9]
Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole., Regula J,Butruk E,Dekkers CP,de Boer SY,Raps D,Simon L,Terjung A,Thomas KB,Lühmann R,Fischer R,, The American journal of gastroenterology, 2006 Aug [PubMed PMID: 16817839]
[10]
Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency., Lam JR,Schneider JL,Zhao W,Corley DA,, JAMA, 2013 Dec 11 [PubMed PMID: 24327038]
[11]
Linder L,Tamboue C,Clements JN, Drug-Induced Vitamin B{sub}12{/sub} Deficiency: A Focus on Proton Pump Inhibitors and Histamine-2 Antagonists. Journal of pharmacy practice. 2017 Dec; [PubMed PMID: 27520327]
[12]
Comparison of Two Versions of the Beers Criteria and Adverse Outcomes in Older Hospitalized Patients., Ozalas SM,Huang V,Brunetti L,Reilly T,, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2017 Dec 1 [PubMed PMID: 29467068]
[13]
Staines KA,Myers K,Little K,Ralston SH,Farquharson C, Proton Pump Inhibitors Inhibit PHOSPHO1 Activity and Matrix Mineralisation In Vitro. Calcified tissue international. 2021 Jul 2; [PubMed PMID: 34213594]
[14]
A case of pantoprazole anaphylaxis with cross reactivity to all proton pump inhibitors: finding a safe alternative., Türedi Ö,Sözener ZÇ,Kendirlinan R,Bavbek S,, Current drug safety, 2017 Jul 11 [PubMed PMID: 28699491]